arrow
L

Lewis C. Cantley

Weill Cornell Medicine
H指数:214
被引数:20.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study

极低碳水化合物生酮饮食在初治未接受过治疗的子宫内膜癌伴超重女性中的随机可行性研究

2026-05-270
OAAI
Author Correction: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

作者更正:对致癌基因消除具有抵抗性的胰腺癌细胞依赖于线粒体功能

Nature
IF48.5
2026-04-080
PRE
Publisher Correction: Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity

出版者更正:基于基序的胞质受体样激酶BIK1底物作图揭示了植物免疫的新型组分和调控节点

2026-03-030
OA
Comprehensive evaluation of phosphoproteomic-based kinase activity inference

基于磷酸蛋白质组学的激酶活性推断的综合评价

2025-05-220
OAAI
Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models

Tyrakis, P.A.等人(2025)多节点抑制靶向mTORC1、mTORC2和PI3Kα,在子宫内膜癌和乳腺癌模型中强效抑制PI3K/AKT/mTOR通路。Br. J. Cancer, 133, 144–154。

2025-05-130
OAAI
Phosphoproteomics-directed manipulation reveals SEC22B as a hepatocellular signaling node governing metabolic actions of glucagon

磷酸化蛋白质组学指导的操作揭示了SEC22B作为控制胰高血糖素代谢作用的肝细胞信号节点

2024-09-271
OAAI
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer

儿童和青少年癌症PI3-K、mTOR、AKT和GSK3β 抑制剂药物开发儿科战略论坛

2024-08-010
PRE
Genome- wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase

球体培养中的全基因组CRISPR筛选揭示了肿瘤抑制因子LKB1通过PIKFYVE脂质激酶抑制生长

2024-05-141
OAAI
The intrinsic substrate specificity of the human tyrosine kinome
Nature
IF48.5
2024-05-080
OAAI